Studies using C3−/− and C5−/− mice models have demonstrated that C3-independent C5 activation occurs in some diseases like acute lung injury (Huber-Lang et al., 2006), LPS-induced fetal loss (Yu et al., 2008), and autoantibody-meditated arthritis (Auger et al., 2012). This evidence concerns the gene C3 and acute lung injury.